Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Devereaux Terah L

(Last) (First) (Middle)


(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Accounting Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 13,091.691 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock (1) (1) Common Stock 400 0 D
Restricted Stock (2) (2) Common Stock 1,506 0 D
Restricted Stock (3) (3) Common Stock 2,179 0 D
Restricted Stock (4) (4) Common Stock 3,065 0 D
Explanation of Responses:
1. Shares vest January 31, 2024.
2. Shares vest in equal annual installments on January 28, 2024 and January 28, 2025.
3. Shares vest in equal annual installments on February 1, 2024, February 1, 2025 and February 1, 2026.
4. Shares vest in four equal annual installments begining February 2, 2024.
/s/ Terah L. Devereaux by Michael B. Kirwan, Power of Attorney 03/15/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Know all by these presents, that, for good and valuable consideration, the
sufficiency and receiptof which are hereby acknowledged, the undersigned
hereby constitutes and appoints Neda A. Sharifi, Michael B. Kirwan
and John J. Wolfel, and each or any of them, the undersigned's
true and lawful attorney-in-fact to:
1. execute for and on behalf of the undersigned (in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended, and the
rules thereunder (the "Exchange Act")), in the undersigned's capacity as an
officer and/or director of Regency Centers Corporation (the "Company"), any
and all Forms 3, 4 and/or 5, and any amendments thereto, that are necessary
or advisable for the undersigned to file under Section 16(a) (such forms
along with the Form ID are collectively, "Documents");
2. do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute any such Documents and
timely file such Documents with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and
3. take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the Documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact (or such attorney-in-
fact's substitute or substitutes) shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that such attorney-in-fact, in serving in such
capacity at the request of the undersigned, is not assuming, nor is such
attorney-in-fact's substitute or substitutes assuming, any of the undersigned's
responsibilities to comply with the Exchange Act. The undersigned agrees to
defend and hold harmless such attorney-in-fact (and such attorney-in-fact's
substitute or substitutes) from and against any and all loss, damage or
liability that such attorney-in-fact may sustain as a result of any action
taken in good faith hereunder.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Documents with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney as of
February 16, 2023.
/s/ Terah L. Devereaux
Signature Name: Terah L. Devereaux